- Home
- WIT vs ASND Comparison
WIT vs ASND Comparison
Compare WIT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WIT | ASND |
|---|---|---|
| Founded | 1945 | 2006 |
| Country | India | Denmark |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0B | 17.7B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WIT | ASND |
|---|---|---|
| Price | $1.75 | $227.31 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 7 | 20 |
| Target Price | $1.75 | ★ $309.22 |
| AVG Volume (30 Days) | ★ 7.3M | 734.6K |
| Earning Date | 10-15-2026 | 11-11-2026 |
| Dividend Yield | ★ 4.68% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.64 | $90.32 |
| Revenue Next Year | $3.02 | $46.90 |
| P/E Ratio | $16.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.59 | $186.05 |
| 52 Week High | $3.09 | $282.15 |
Technical Indicators
Market Signals| Indicator | WIT | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 58.31 | 39.06 |
| Support Level | $1.78 | $214.28 |
| Resistance Level | $1.93 | $246.56 |
| Average True Range (ATR) | 0.04 | 9.20 |
| MACD | 0.01 | -1.65 |
| Stochastic Oscillator | 88.46 | 19.92 |
Price Performance
Historical ComparisonAbout WIT Wipro Limited
Wipro is a multinational IT services provider based in Bengaluru, India. The company pivoted into the IT space in the 1980s and grew into one of the largest Indian IT consulting companies during the dot-com boom. Nowadays, Wipro leverages its offshore outsourcing model to derive a significant portion of its revenue from North America and Europe.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.